SEARCH   
MEMBER LOGIN    
Forgot Password?

Generic Pharmaceutical Manufacturing in Canada: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Generic Pharmaceutical Manufacturing in Canada Market Research Report | NAICS 32541bCA | Jan 2017

Drug of choice: A new wave of patent expirations will spur demand for industry products

The Generic Pharmaceutical Manufacturing market research report provides key industry analysis and industry statistics, measures market size, analyzes current and future industry trends and shows market share for the industry’s largest companies. IBISWorld publishes the largest collection of industry reports so you can see an industry’s supply chain, economic drivers and key buyers and markets.

Report Snapshot
Market Share of Companies
Industry Statistics & Market Size
Revenue
$6bn
Annual Growth 11-16
5.4%
Annual Growth 16-21
Add to Cart
Profit
Add to Cart
Employment
11,354
Businesses
190
Industry Analysis & Industry Trends

After experiencing low export demand and severe pricing pressures over the past five years, the Generic Pharmaceutical Manufacturing industry has significant opportunities to grow in the five years to 2021. A new wave of patent expirations and the growing market for biosimilars are expected to spur demand for new industry products. The industry will likely expand to meet this demand, with new companies increasingly attracted to the industry's new markets and growing profit margins. However, research and development costs will continue to limit profit growth and the threat of further provincial reimbursement cuts for generic pharmaceuticals remains high... purchase to read more

Industry Report - Industry Products Chapter

Nervous system and cardiovascular system drugs

Nervous system therapies are expected to account for 20.1% of industry revenue in 2016, whereas cardiovascular system drugs make up an additional 15.6% of total revenue. This segment includes a wide variety of pharmaceutical preparations intended to treat a broad spectrum of conditions, including central nervous systems disorders, psychological disorders, dementia, seizures and movement disorders. Anesthesia products and muscle relaxants are also included in this segment, as are some drugs designed to counteract the effects of narcotics and alcohol. Nervous system therapies are particularly commonly prescribed among people aged 65 and under. Acc.. purchase to read more

 


Industry ProductsRelated ReportsTable of Contents

What is the Generic Pharmaceutical Manufacturing Industry?

This industry develops prescription and over-the-counter drug products that are used to prevent or treat illnesses in humans or animals. Generic drugs are produced and distributed without patent protection and industry operators are not significantly engaged in the research and development of new drugs. The industry does not include manufacturers of nutritional supplements or cosmetic beauty products.

Industry Products
Nervous system and cardiovascular systemAntineoplastic and immunomodulating agentsAlimentary tract and metabolismRespiratory system and sensory organs Antiinfectives for systemic use and blood/blood-forming organ drugsMusculoskeletal system Genitourinary system and hormones
 
Industry Activities
Gaining regulatory approval for generic drugsDeveloping and producing generic drugsMarketing and distributing generic drugs


View Sample
Quote
Select Clients